CDC | TB Notes 4, 2009 | New CDC Publications

TB Notes Newsletter
(PDF - 1M - 26 pages -
http://www.cdc.gov/tb/publications/newsletters/notes/TBN_4_09/images/tbn409.pdf)
No. 4, 2009


New CDC Publications
1. Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, Sinthuwatanawibool C, Rujiwongsakorn S, Nakara P, Komsakorn S, Wattanaamornkiet W, Moolphate S, Chiengsorn N, Kaewsaard S, Nateniyom S, Varma JK. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Tropical Medicine & International Health 2009 Nov; 14(11):1338-1346.

2. Cummings KJ, Smith TS, Shogren ES, Khakoo R, Nanda S, Bunner L, Smithmyer A, Soccorsi D, Kashon ML, Mazurek GH, Friedman LN, Weissman DN. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. [Concise communication.] Infection Control & Hospital Epidemiology 2009 Nov; 30(11):1123-1126.

3. Frieden TR, Teklehaimanot A, Chideya S, Farmer P, Kim JY, Raviglione MC. A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS. Arch Intern Med 2009;169 (18):1650-1652.

4. Heffelfinger JD, Patel P, Brooks JT, Calvet H, Daley CL, Dean HD, Edlin BR, Gensheimer KF, Jereb J, Kent CK, Lennox JL, Louie JK, Lynfield R, Peters PJ, Pinckney L, Spradling P, Voetsch AC, Fiore A. Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis. American Journal of Public Health 2009 Oct; 99(Suppl 2):S333-S339.

5. Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P, and the Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in the United States and Canada. Chest 2009 Nov.

6. Lonnroth L, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2009;1–7. Advance Access e-published October 9, 2009 (doi:10.1093/ije/dyp308).

7. Marks S. Socio-economic determinants of tuberculosis in Recife, Brazil. [Commentary.] International Journal of Epidemiology 2009 Oct; 38(5):1295-1296.

8. Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Dung NH, Lan NTN, Yen NTB, Teeratakulpisarn N, Udomsantisuk N, Heilig C, and Varma JK. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009; 180: 903–908.

9. Ngamlert K, Sinthuwattanawibool C, McCarthy KD, Sohn H, Starks A, Kanjanamongkolsiri P, Anek-vorapong R, Tasaneeyapan T, Monkongdee P, Diem L, Varma JK. Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Tropical Medicine & International Health 2009 July; 14(7):748-753.

10. Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2009 Nov 30. [Epub ahead of print].

11. Wang S-H, Pancholi P, Stevenson K, Yakrus MA, Butler WR, Schlesinger LS, Mangino JE. Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infection Control & Hospital Epidemiology 2009 Sept; 30(9): 848-853.

12. Winthrop KL, Chiller T. Preventing and treating biologic-associated opportunistic infections. Nature Reviews Rheumatology 2009 July; 5(7):405-410.